Browse
Drugs
Categories
Pathways
Drug Reactions
Drug Classification
Drug Targets
Pharmaco-genomics
Pharmaco-metabolomics
Pharmaco-transcriptomics
Pharmaco-proteomics
COVID-19
Search
Chemical Structure
Molecular Weight
Drug & Food Interactions
Target Sequences
Pharmaco-omics
Advanced Search
MS Search
MS/MS Search
GC/MS Search
1D NMR Search
2D NMR Search
Downloads
Commercial Data
Products
Clinical Drug Data
Scientific Drug Data
Industries
Drug Discovery Drug Repurposing Precision Medicine Machine Learning
Resources
White Papers
Help
Help Center
Quick Links
Citing DrugBank
DrugBank.ca FAQs
Searching DrugBank
Other Databases
Data Sources
About
About DrugBank.ca
Statistics
Blog
Wishart Research Group
Contact Us

Oral Oxycodone With/Without Naloxone

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB01183	Naloxone	4	Completed	1
DB00497	Oxycodone	4	Completed	1

About

About DrugBank.ca
Blog
Wishart Research Group
Careers
Terms of Use
Privacy Policy

Support

Help Center
DrugBank.ca FAQs
Contact Support

Commercial Data

Clinical Drug Data
Scientific Drug Data
Contact Sales

This project is supported by the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Alberta, Genome British Columbia, and Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with funding from the federal government. Maintenance, support, and commercial licensing is provided by OMx Personal Health Analytics, Inc. Designed by Educe Design & Innovation Inc.